Evidence map›Paper›PMID 24854621›Full record

ArticleRNA (New York, N.Y.)2014

Disparate HDV ribozyme crystal structures represent intermediates on a rugged free-energy landscape.

Kamali N Sripathi, Wendy W Tay, Pavel Banáš, Michal Otyepka, Jiří Šponer, Nils G Walter

Open access · bronzeAbstract read
In one paragraph

Article in RNA (New York, N.Y.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Kamali N SripathiDepartment of Medicinal Chemistry, University of Michigan, Ann Arbor, Michigan 48109-1065, USA.
Wendy W TayProgram in Chemical Biology, University of Michigan, Ann Arbor, Michigan 48109-1055, USA.
Pavel BanášRegional Centre of Advance Technologies and Materials, Department of Physical Chemistry, Faculty of Science, Palacký University, 771 46 Olomouc, Czech Republic.
Michal OtyepkaRegional Centre of Advance Technologies and Materials, Department of Physical Chemistry, Faculty of Science, Palacký University, 771 46 Olomouc, Czech Republic.
Jiří ŠponerInstitute of Biophysics, Academy of Sciences of the Czech Republic, 612 65 Brno, Czech Republic Masaryk University, Campus Bohunice, 625 00 Brno, Czech Republic.
Nils G WalterDepartment of Chemistry, Single Molecule Analysis Group, University of Michigan, Ann Arbor, Michigan 48109-1055, USA.
University of Michigan · USRegional Centre of Advanced Technologies and Materials · CZCzech Academy of Sciences · CZ

Funding

U-turn of the Hepatitis Delta Virus RibozymeR01GM062357 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WALTER, NILS G · 2001 to 2019
$5.8M
NIGMS NIH HHS R01 GM062357
6 · The paper itself

Abstract

The hepatitis delta virus (HDV) ribozyme is a member of the class of small, self-cleaving catalytic RNAs found in a wide range of genomes from HDV to human. Both pre- and post-catalysis (precursor and product) crystal structures of the cis-acting genomic HDV ribozyme have been determined. These structures, together with extensive solution probing, have suggested that a significant conformational change accompanies catalysis. A recent crystal structure of a trans-acting precursor, obtained at low pH and by molecular replacement from the previous product conformation, conforms to the product, raising the possibility that it represents an activated conformer past the conformational change. Here, using fluorescence resonance energy transfer (FRET), we discovered that cleavage of this ribozyme at physiological pH is accompanied by a structural lengthening in magnitude comparable to previous trans-acting HDV ribozymes. Conformational heterogeneity observed by FRET in solution appears to have been removed upon crystallization. Analysis of a total of 1.8 µsec of molecular dynamics (MD) simulations showed that the crystallographically unresolved cleavage site conformation is likely correctly modeled after the hammerhead ribozyme, but that crystal contacts and the removal of several 2'-oxygens near the scissile phosphate compromise catalytic in-line fitness. A cis-acting version of the ribozyme exhibits a more dynamic active site, while a G-1 residue upstream of the scissile phosphate favors poor fitness, allowing us to rationalize corresponding changes in catalytic activity. Based on these data, we propose that the available crystal structures of the HDV ribozyme represent intermediates on an overall rugged RNA folding free-energy landscape.

Indexed as

CatalysisCatalytic DomainCrystallography, X-RayFluorescence Resonance Energy TransferHepatitis Delta VirusKineticsModels, MolecularMolecular Dynamics SimulationNucleic Acid ConformationRNA, CatalyticRNA CleavageRNA, Small NuclearRNA, Viralhammerhead ribozymeRNA, CatalyticRNA, Small NuclearRNA, ViralU1 small nuclear RNAconformational changemolecular dynamics simulationsmall ribozymesteady-state FRETtime-resolved FRET

Identifiers

PMID24854621
PMCPMC4114689
OpenAlexW2111576030

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.